Title of Activity: Urticaria: Diagnostic and Treatment Considerations

Faculty: Adam Friedman, MD, FAAD

Release Date: 11/15/2019
Expiration Date: 11/01/2022
Review Date: 10/29/2022
Expiration Date: 11/1/2023
Review Date: 09/21/2023
Extended Expiration Date: 11/1/2025

Target Audience:
RNs, NPs, LPNs and other healthcare providers with a professional interest in dermatology.

Estimated time for completion: 1 hour

The fee for this activity is: $15 members/$25 non-members

This activity is awarded: 1.0 contact hour(s).

CREDIT INFORMATION

Nurses:

The Dermatology Nurses' Association (DNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

To Receive Credit:

Watch the video in its entirety.
Complete/submit the post test and evaluation.
Receive a passing score of 70% or more to receive credit.
Print out your certificate, as well as save it to your computer.

PROGRAM OVERVIEW

Program Purpose: The purpose of this activity is for the learner to be able to recognize urticaria and formulate appropriate workups and treatment strategies.

Learning Objectives: Upon successful completion of this educational program, the participant should be able to:

Appropriately diagnose and distinguish between acute and chronic urticaria (CU) subtypes
Implement appropriate evidence-based recommendations for a stepwise approach to the treatment of patients with CU
Analyze the safety and efficacy of available and emerging immunobiologic therapies for refractory CU
Utilize standardized tools to assess disease severity, response to treatment, and QoL in patients who suffer from urticaria

DISCLOSURES

Planning committee members:

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner

Kristen Miller, MSN, FNP, Nurse Planner

Kathryn Ciccolini, AGACNP-BC, MSN, OCN, DNC, Content Expert
have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty:

Adam Friedman, MD, FAAD
has disclosed that he has no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Any potential conflict of interest has been vetted according to policy and the determination was made that no conflict existed.

COMMERCIAL SUPPORT OR NON-COMMERCIAL SPONSORSHIP

There is no commercial support for this activity.

Adam Friedman MD, FAAD

Professor of Dermatology, Residency Program Director, Director of Translational Research, GW Medical Faculty Associates

Appearances